Chelidamic acid

CAS No. 138-60-3

Chelidamic acid( —— )

Catalog No. M20536 CAS No. 138-60-3

Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Chelidamic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.
  • Description
    Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid is inhibitors of glutamate decarboxylase with a Ki of 33 μM.
  • In Vitro
    Chelidamic acid is a heterocyclic organic acid with a pyran skeleton. Chelidamic acid has good coordination ability with noble metal ions. Chelidamic acid is also one of the most potent inhibitors of glutamate decarboxylase, with a Ki of 33 μM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    Glutamate Transporters
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    138-60-3
  • Formula Weight
    183.12
  • Molecular Formula
    C7H5NO5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:36 mg/mL (196.59 mM)
  • SMILES
    OC(=O)c1cc(=O)cc([nH]1)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Porter T G Martin D L . Chelidonic acid and other conformationally restricted substrate analogues as inhibitors of rat brain glutamate decarboxylase[J]. Biochemical Pharmacology 1986 34(23):4145-4150.
molnova catalog
related products
  • HBT1

    HBT1 is an AMPA receptor potentiator that induces production of brain-derived neurotrophic factor (BDNF) and exhibits little agonistic effect in primary neurons. HBT1 binds to ligand-binding domain of AMPA-R in glutamate dependent manner.HBT1 bound to the ligand-binding domain (LBD) of AMPA-R in a glutamate-dependent manner.?

  • Motolimod

    Motolimod (VTX-2337) is an effective and specific Toll-like receptor (TLR) 8 agonist (EC50: 100 nM), > 50-fold selectivity over TLR7.

  • S-Sulfo-L-cysteine s...

    S-Sulfo-L-cysteine sodium salt shows a weak affinity for mGluR1α and mGluR5a at high concentrations and has potential antioxidant activity.